These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 582147)

  • 1. Disposition rate of proscillaridin A in man after multiple oral doses.
    Bergdahl B
    Arzneimittelforschung; 1979; 29(2):343-5. PubMed ID: 582147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations during repeated intravenous and oral methyl-proscillaridin application in man.
    Belz GG; Nübling H; Belz G
    Arzneimittelforschung; 1976 Feb; 26(2):277-8. PubMed ID: 947212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the pharmacokinetics of proscillaridin A in man.
    Andersson KE; Bertler A; Redfors A
    Eur J Clin Pharmacol; 1975 Aug; 8(6):421-5. PubMed ID: 1233243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of proscillaridin A in thoracic duct lymph after single oral doses in man.
    Andersson KE; Bergdahl B; Dencker H; Wettrell G
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):280-4. PubMed ID: 576557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary excretion and enterochepatic recycling of proscillaridin A after oral adminstration to man.
    Andersson KE; Bergdahl B; Wettrell G
    Eur J Clin Pharmacol; 1977 Apr; 11(4):273-6. PubMed ID: 862647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the absorption of proscillaridin A after single oral doses to normal and achlorhydric subjects.
    Andersson KE; Bergdah B; Bertler A; Redfors A
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):153-60. PubMed ID: 576356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enteral availability and therapeutic activity of proscillaridin-4'-methyl ether (author's transl)].
    Krämer KD; Hochrein H
    Arzneimittelforschung; 1976 Apr; 26(4):579-83. PubMed ID: 989015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of tables facilitating daily control of treatment with proscillaridin A].
    Tytman B
    Pol Tyg Lek; 1979 Dec; 34(49):1917-21. PubMed ID: 575563
    [No Abstract]   [Full Text] [Related]  

  • 9. Stability in vitro of methylproscillaridin.
    Bergdahl B; Andersson KE
    Eur J Clin Pharmacol; 1977 Apr; 11(4):267-71. PubMed ID: 16755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of mathematical methods and computer technics for monitoring the concentration of digitalis glycosides in the body of patients with symptoms of overdigitalization].
    Tytman B
    Pol Tyg Lek; 1981 Mar; 36(10):373-7. PubMed ID: 7279733
    [No Abstract]   [Full Text] [Related]  

  • 11. The bioavailability of methylepoxyproscillaridin (P35): a new semisynthetic cardiac glycoside.
    Bonelli J; Waginger W; Gazo F
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):297-9. PubMed ID: 3410606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro stability of proscillaridin A.
    Andersson KE; Bertler A; Redfors A
    Eur J Clin Pharmacol; 1975 Feb; 8(2):135-9. PubMed ID: 9294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meproscillarin in patients with renal failure and concomitant heart failure (author's transl)].
    Beckmann H; Belz GG; Quellhorst E
    Med Klin; 1979 Nov; 74(47):1761-6. PubMed ID: 522817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proscillaridin activity in portal and peripheral venous blood after oral administration to man.
    Andersson KE; Bergdahl B; Dencker H; Wettrell G
    Eur J Clin Pharmacol; 1977 Apr; 11(4):277-81. PubMed ID: 862648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma concentration and elimination behavior of the cardiac glycoside meproscillarin in patients with liver cirrhosis].
    Burkert K; Beckmann H
    Z Gastroenterol; 1983 Jan; 21(1):34-40. PubMed ID: 6845784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of methyl proscillaridin in healthy man.
    Belz GG; Schreiter H; Wolf GK
    Eur J Clin Pharmacol; 1976 Jun; 10(2):101-8. PubMed ID: 786669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Studies on pharmacokinetics of proscillaridin-4'-methyl ether in man.
    Belz GG
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R7. PubMed ID: 4276519
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma levels of mepindolol in healthy volunteers after oral doses of mepindolol sulphate.
    Krause W; Schwartzkopff W
    Arzneimittelforschung; 1983; 33(9):1306-7. PubMed ID: 6685513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose pharmacokinetics of cetirizine in young and elderly volunteers.
    Lefebvre RA; Rosseel MT; Bernheim J
    Int J Clin Pharmacol Res; 1988; 8(6):463-70. PubMed ID: 2908109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
    Klotz U; Avant GR; Hoyumpa A; Schenker S; Wilkinson GR
    J Clin Invest; 1975 Feb; 55(2):347-59. PubMed ID: 1127104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.